Compare ARCO & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCO | IMNM |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | Uruguay | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2011 | 2020 |
| Metric | ARCO | IMNM |
|---|---|---|
| Price | $7.40 | $23.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $8.60 | ★ $26.89 |
| AVG Volume (30 Days) | 1.0M | ★ 1.2M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | ★ 69.06 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $4,555,936,000.00 | $9,679,000.00 |
| Revenue This Year | $6.39 | N/A |
| Revenue Next Year | $7.36 | N/A |
| P/E Ratio | $6.42 | ★ N/A |
| Revenue Growth | ★ 1.21 | N/A |
| 52 Week Low | $6.51 | $5.15 |
| 52 Week High | $8.52 | $20.80 |
| Indicator | ARCO | IMNM |
|---|---|---|
| Relative Strength Index (RSI) | 53.20 | 70.11 |
| Support Level | $7.45 | $18.81 |
| Resistance Level | $7.80 | $20.80 |
| Average True Range (ATR) | 0.18 | 1.45 |
| MACD | -0.01 | 0.16 |
| Stochastic Oscillator | 38.52 | 72.56 |
Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.